The photographer Peter Duke is on a mission to make reactionaries look glamorous.
NYS Entity Status
NYS Filing Date
APRIL 02, 2014
NYS DOS ID#
47-43 47TH ST APT 1R
WOODSIDE, NEW YORK, 11377
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - LEE MELTZER PHOTOGRAPHY LLC
AROUND THE WEB
- The Annie Leibovitz of the Alt-Right
By MATTHEW KASSEL - Thursday Jul 20, 2017
- Listing of the Day: Woodside, California
Friday Jul 28, 2017
This mid-century modern home was recently renovated to highlight its original charm, but include all the modern updates of a true tech-elite lifestyle.
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
- In the Huddle With NY Jets Owner Woody Johnson
Friday Oct 15, 2010
Woody Johnson, owner of the New York Jets NFL franchise, joins WSJ's Lee Hawkins for the "WSJ Weekend Conversations" series to talk about the Jets' Super Bowl prospects, co-chairing the 2014 Super Bowl host committee, and his charitable interests.
- Striking elegance awaits in Woodside
Thursday Jun 29, 2017
Twice a week, The Chronicle features a home on the market that caught our eye for its architecture, history or character. Crisp lines, soaring ceilings, sweeping vistas and sunny spaces define this new construction in Woodside. Both structures enjoy similar material palettes loaded with custom doors and windows, built-in speakers, stainless steel appliances and retractable glass panels. The master suite enjoys a private balcony, and its lavish spa bathroom includes both an oversized Neptune tub and a walk-in shower beneath a skylight. The landscape offers a covered lanai, speakers, an indoor/outdoor fireplace and a fire-pit patio. The Walk-Through is produced by Sentinel Media Services for The San Francisco Chronicle.
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]